New SPECT System Launched as Nuclear Cardiology Solution
By MedImaging International staff writers Posted on 26 Sep 2017 |
Image: The new CardioMD IV SPECT solution (Photo courtesy of Philips Healthcare).
A large global healthcare equipment manufacturer has highlighted a new nuclear cardiology solution that uses Single Photon Emission Computed Tomography (SPECT) technology, cardiac quantification software, and advanced reconstruction to improve the cardiac imaging workflow and diagnostic confidence.
The system was designed specifically as a cardiac SPECT solution that fits the needs of healthcare institutions, both economic, and clinical.
The novel CardioMD IV cardiac SPECT system was developed by Royal Philips (Amsterdam, the Netherlands). The system has a small footprint, and is designed to fit in an existing camera room without the need for costly room renovations. The system has a patient-friendly design, and offers improved positioning flexibility. The CardioMD IV can perform cardiac imaging much faster than previous systems.
The CardioMD IV also features Philips’ Astonish reconstruction technology that can improve workflow efficiency, while providing the same image quality. The system also works with Philips’ IntelliSpace Portal advanced visualization, and analysis platform. By using IntelliSpace the CardioMD IV SPECT reporting, quantification, and review applications become available to the whole enterprise, and can facilitate more efficient collaboration between referring physicians, and cardiologists.
Business Leader, Advanced Molecular Imaging, at Philips Healthcare, Kirill Shalyaev, PhD, said, "Our aim is to advance molecular imaging in all disease areas, and provide dependable imaging solutions to enhance diagnostic confidence and patient care at lower costs. CardioMD IV delivers the reliable performance and the low total cost of ownership that nuclear cardiology practices need to drive clinical, financial and operational efficiencies."
The system was designed specifically as a cardiac SPECT solution that fits the needs of healthcare institutions, both economic, and clinical.
The novel CardioMD IV cardiac SPECT system was developed by Royal Philips (Amsterdam, the Netherlands). The system has a small footprint, and is designed to fit in an existing camera room without the need for costly room renovations. The system has a patient-friendly design, and offers improved positioning flexibility. The CardioMD IV can perform cardiac imaging much faster than previous systems.
The CardioMD IV also features Philips’ Astonish reconstruction technology that can improve workflow efficiency, while providing the same image quality. The system also works with Philips’ IntelliSpace Portal advanced visualization, and analysis platform. By using IntelliSpace the CardioMD IV SPECT reporting, quantification, and review applications become available to the whole enterprise, and can facilitate more efficient collaboration between referring physicians, and cardiologists.
Business Leader, Advanced Molecular Imaging, at Philips Healthcare, Kirill Shalyaev, PhD, said, "Our aim is to advance molecular imaging in all disease areas, and provide dependable imaging solutions to enhance diagnostic confidence and patient care at lower costs. CardioMD IV delivers the reliable performance and the low total cost of ownership that nuclear cardiology practices need to drive clinical, financial and operational efficiencies."
Latest Nuclear Medicine News
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure
- New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease